Literature DB >> 9886997

beta-alanine and alpha-fluoro-beta-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2.

M Liu1, R L Russell, L Beigelman, R E Handschumacher, G Pizzorno.   

Abstract

Studies on the compartmentalization of uridine catabolic metabolism in liver have indicated accumulation of beta-alanine as well as alpha-fluoro-beta-alanine (FbetaAL) for 5-fluorouracil in the hepatocytes. Using preparations of rat hepatocytes we were able to identify a Na+-dependent transport with high affinity for beta-alanine and GABA with Michaelis constant (Km) of 35.3 and 22.5 microM, respectively. A second Na+-dependent kinetic component with Km >1 mM was also identified. The sigmoidal profile of beta-alanine uptake with respect to Na+ shows the involvement of multiple ions of sodium in the transport process. A Hill coefficient of 2.6 +/- 0.4 indicates that at least two sodium ions are cotransported with beta-alanine. The flux of beta-alanine was also shown to be chlorine dependent. The substitution of this anion with gluconate, even in the presence of Na+, reduced the intracellular concentrative accumulation of beta-alanine to passive diffusion level, indicating that both Na+ and Cl- are essential for the activity of this transporter. The transport of beta-alanine was inhibited by GABA, hypotaurine, beta-aminoisobutyric acid, and FbetaAL in a competitive manner. However, concentrations up to 1 mM of L- and D-alanine, taurine, and alpha-aminoisobutyric acid did not affect beta-alanine uptake. Considering the similarities in substrate specificity with the rat GAT-2 transporter, extracts of hepatocytes were probed with the anti-GABA transporter antibody R-22. A 80-kDa band corresponding to GAT-2 was present in the hepatocyte and in the GAT-2 transfected Madin-Darby canine kidney cell extract, confirming the extraneural localization of this transporter. In view of these results, the neurotoxic effects related to the administration of uridine and 5-fluorouracil could be explained with the formation of beta-alanine and FbetaAL and their effect on the cellular reuptake of GABA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886997     DOI: 10.1152/ajpgi.1999.276.1.G206

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  The effect of 4 weeks beta-alanine supplementation and isokinetic training on carnosine concentrations in type I and II human skeletal muscle fibres.

Authors:  Iain P Kendrick; Hyo Jeong Kim; Roger Charles Harris; Chang Keun Kim; Viet H Dang; Thanh Q Lam; Toai T Bui; John A Wise
Journal:  Eur J Appl Physiol       Date:  2009-02-12       Impact factor: 3.078

2.  δ-Aminolevulinic acid and its methyl ester induce the formation of Protoporphyrin IX in cultured sensory neurones.

Authors:  B Novak; R Schulten; H Lübbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-25       Impact factor: 3.000

3.  β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.

Authors:  Lee D Roberts; Pontus Boström; John F O'Sullivan; Robert T Schinzel; Gregory D Lewis; Andre Dejam; Youn-Kyoung Lee; Melinda J Palma; Sondra Calhoun; Anastasia Georgiadi; Ming-Huei Chen; Vasan S Ramachandran; Martin G Larson; Claude Bouchard; Tuomo Rankinen; Amanda L Souza; Clary B Clish; Thomas J Wang; Jennifer L Estall; Alexander A Soukas; Chad A Cowan; Bruce M Spiegelman; Robert E Gerszten
Journal:  Cell Metab       Date:  2014-01-07       Impact factor: 27.287

4.  SNAT2 amino acid transporter is regulated by amino acids of the SLC6 gamma-aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission.

Authors:  Sukhjeevan Grewal; Norah Defamie; Xiong Zhang; Stéphanie De Gois; Ali Shawki; Bryan Mackenzie; Chu Chen; Hélène Varoqui; Jeffrey D Erickson
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

5.  γ-Aminobutyric acid transporter 2 mediates the hepatic uptake of guanidinoacetate, the creatine biosynthetic precursor, in rats.

Authors:  Masanori Tachikawa; Saori Ikeda; Jun Fujinawa; Shirou Hirose; Shin-ichi Akanuma; Ken-ichi Hosoya
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 6.  Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.

Authors:  Nattawut Leelakanok; Sean Geary; Aliasger Salem
Journal:  J Pharm Sci       Date:  2017-10-16       Impact factor: 3.784

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.